Apple Liquid Design interface across platforms including-iOS 26, iPadOS 26, macOS Tahoe 26, watchOS 26, tvOS 26-has been ...

As people share their opinions online and fear of missing out soars, many are linking this trend to the early days of Dogecoin and Shiba Inu but think this one has more advanced technology behind it.

A teenage investor who gained $500 million from a 500% surge in Hyperliquid is now turning attention to XYZVerse. Believing ...

Dogecoin (DOGE) has long been a favorite among crypto enthusiasts for its meme-inspired origins and viral community support.

On June 1, Allogene Therapeutics Inc. (NASDAQ:ALLO) presented updated data from the Phase 1 TRAVERSE study of ALLO-316 in advanced or metastatic renal cell carcinoma/RCC during an oral ...

“We are thrilled with the successful completion of the Phase 1 SAD study, which demonstrated the safety and tolerability of TIX100 in humans,” said Dr. Anath Shalev, Founder and Chief ...

Bicara Therapeutics Inc. has announced promising data from its Phase 1/1b clinical trial of ficerafusp alfa, a novel bifunctional antibody, in combination with pembrolizumab for treating first ...

INB-200 shows significantly improved progression-free survival in glioblastoma patients, with favorable safety profile and no serious toxicities reported. Repeated doses of INB-200 demonstrated an ...

KUCHING: The overall progress of phase one of the Kuching Urban Transportation System (KUTS) project stood at 29.89% as of April this year, the Sarawak Legislative Assembly was told. State Deputy ...

Mumbai: Ichnos Glenmark Innovation (IGI), a joint venture between Glenmark Pharmaceuticals and Ichnos Sciences, on Monday shared promising results from an ongoing phase-1 trial of ISB 2001 ...

today announced that the first patient has been dosed in its Phase I single-center clinical trial in the United States designed to evaluate safety, pharmacokinetics and pharmacodynamics ...

The Phase 1/2a study, AROALK7-1001, recently dosed its first participants. In addition to a single agent, the study will employ combination approaches using tirzepatide in obese individuals ...